AC Immune Receives Second Milestone Payment Following Progress in Phase 2b ReTain Trial of ACI-35.030 in Preclinical Alzheimer’s Disease AC Immune Receives Second Milestone Payment Following Progress in Phase 2b ReTain Trial of ACI-35.030 in Preclinical Alzheimer’s Disease Prescreening rate of Phase 2b ReTain trial triggers clinical...

AC Immune’s ACI-35.030 (now “JNJ-2056”) Granted FDA Fast Track Designation for Alzheimer’s Disease AC Immune’s ACI-35.030 (now “JNJ-2056”) Granted FDA Fast Track Designation for Alzheimer’s Disease Treatment of first randomized person with preclinical AD expected this quarterPhase 2b ReTain...

Engage2Excel Supports SmartWorks Collaborative Virtual Event Featuring a Panel of Experts on Challenges of Managing and Retaining Today's Workforce MOORESVILLE, N.C., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Engage2Excel, Inc., an industry-leading provider of recruitment, recognition, and engagement solutions, invites all managers and leaders to...

Anita Borg Institute Unveils Roster of Speakers Participating in Top Company for Technical Women Workshop PALO ALTO, CA--(Marketwire - March 21, 2011) - The Anita Borg Institute for Women and Technology (ABI) announced today the speakers and topics for the inaugural Anita Borg Top Company for Technical...

Recruiters at ERE Expo Say Competition for Top Candidates and Retention Are Biggest Challenges NEW YORK, NY--(Marketwire - October 25, 2007) - More than 500 recruiters recently convened in Washington, D.C., for the 2007 Fall ERE Expo. Recruiting leaders from George Mason University, MITRE...